IP Library Granted Patent US 9,782,523
Granted Patent B2
US 9,782,523 · App. 13/101,391 · Granted Oct 10, 2017

Side-chain crystallizable polymers for medical applications

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,782,523
App. No.
13/101,391
Granted
Oct 10, 2017
Kind
B2
Abstract

Side-chain crystallizable (SCC) polymers are useful in various medical applications. In certain applications, heavy atom containing side-chain crystallizable polymers (HACSCCP's) are particularly useful. An example of a HACSCCP is a polymer that comprises a main chain, a plurality of crystallizable side chains, and a plurality of heavy atoms attached to the polymer. In certain configurations, the heavy atoms are present in an amount that is effective to render the polymer radiopaque. A polymeric material that includes an HACSCCP may be fabricated into a medical device useful for at least partially occluding a body cavity. For example, such a medical device may be an embolotherapy product. A polymeric material that includes a SCC polymer may also be fabricated into other medical devices, such as stents.

Claims (14)

1. A side chain crystallizable polymer comprising:

a main chain;

a plurality of crystallizable side chains; and

a plurality of heavy atoms attached to the polymer, the heavy atoms being present in an amount that is effective to render the polymer radiopaque;

wherein the polymer comprises a recurring unit of the formula (VI):

wherein R 12 is H or CH 3 and n4 is an integer in the range of about 1 to about 1,000.

2. The side chain crystallizable polymer of claim 1 , wherein N4 is an integer in the range of about 2 to about 10.

3. The side chain crystallizable polymer of claim 1 , further comprising a recurring unit of the formula (II):

wherein R 7 is H or CH 3 ; A 3 is a chemical group having a molecular weight of about 500 or less; and A 3 bears at least one of the heavy atoms attached to the polymer.

4. The side chain crystallizable polymer of claim 1 that is biocompatible.

5. A medical device comprising the side chain crystallizable polymer of claim 1 .

6. A method of making the side chain crystallizable polymer of claim 1 , comprising:

providing a polymer that comprises recurring hydroxyethylmethacrylate units; and

reacting at least a portion of the hydroxyethylmethacrylate units with caprolactone.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2020
From: REVA MEDICAL, INC.
To: REVA MEDICAL, LLC
Reel/Frame 054778/0748 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Feb 27, 2020
From: GOLDMAN SACHS INTERNATIONAL, AS ADMINISTRATIVE AGENT
To: REVA MEDICAL, INC.
Reel/Frame 052045/0383 →
NOTICE OF GRANT OF SECURITY INTEREST IN U.S. PATENTS Recorded Apr 9, 2019
From: REVA MEDICAL, INC.
To: GOLDMAN SACHS INTERNATIONAL AS ADMINISTRATIVE AGENT
Reel/Frame 048834/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2011
From: BRANDOM, DONALD K.; MCGARTH, JAMES E.; ZELTINGER, JOAN; SCHMID, ERIC V.; SCHULTZ, ROBERT K.
To: REVA MEDICAL, INC.
Reel/Frame 026256/0674 →